Caporino Nicole E, Read Kendra L, Shiffrin Nina, Settipani Cara, Kendall Philip C, Compton Scott N, Sherrill Joel, Piacentini John, Walkup John, Ginsburg Golda, Keeton Courtney, Birmaher Boris, Sakolsky Dara, Gosch Elizabeth, Albano Anne M
a Department of Psychology , Georgia State University.
b Department of Psychology , Temple University.
J Clin Child Adolesc Psychol. 2017 Sep-Oct;46(5):675-685. doi: 10.1080/15374416.2015.1063429. Epub 2015 Oct 14.
This study examined (a) demographic and clinical characteristics associated with sleep-related problems (SRPs) among youth with anxiety disorders, and (b) the impact of anxiety treatment: cognitive-behavioral therapy (CBT; Coping Cat), medication (sertraline), their combination, and pill placebo on SRPs. Youth (N = 488, ages 7-17, 50% female, 79% White) with a principal diagnosis of generalized anxiety disorder, separation anxiety disorder, or social phobia participated. SRPs were reported by parents and youth. Findings differed by informant and by type of SRP, with evidence that SRPs are associated with age, anxiety severity, externalizing problems, functional impairment, and family burden at pretreatment. Anxiety treatment reduced SRPs; effect sizes were small to medium. Reductions in parent-reported separation-related sleep difficulties were significantly greater in active treatment than in the placebo condition, with the greatest reductions reported by parents of youth whose active treatment was multimodal or included sertraline. Youth whose anxiety treatment involved CBT reported significantly greater decreases in dysregulated sleep (e.g., sleeplessness). Both CBT for anxiety and sertraline appear to be somewhat effective in reducing SRPs, and multimodal treatment may be preferable depending on the symptom presentation. To inform practice, future research should examine a broad range of SRPs, incorporate objective measures of sleep, and evaluate the impact of behavioral strategies that directly target SRPs in youth with anxiety disorders.
(a)焦虑症青少年中与睡眠相关问题(SRPs)相关的人口统计学和临床特征;以及(b)焦虑症治疗(认知行为疗法(CBT;应对猫疗法)、药物治疗(舍曲林)、二者联合治疗以及药丸安慰剂)对SRPs的影响。主要诊断为广泛性焦虑症、分离性焦虑症或社交恐惧症的青少年(N = 488,年龄7 - 17岁,50%为女性,79%为白人)参与了研究。SRPs由父母和青少年报告。研究结果因报告者和SRP类型而异,有证据表明在治疗前SRPs与年龄、焦虑严重程度、外化问题、功能损害和家庭负担有关。焦虑症治疗减少了SRPs;效应大小为小到中等。在积极治疗组中,父母报告的与分离相关的睡眠困难的减少显著大于安慰剂组,积极治疗为多模式或包含舍曲林的青少年的父母报告的减少幅度最大。焦虑症治疗采用CBT的青少年报告睡眠失调(如失眠)的减少更为显著。焦虑症的CBT治疗和舍曲林在减少SRPs方面似乎都有一定效果,根据症状表现,多模式治疗可能更可取。为指导实践,未来的研究应考察更广泛的SRPs,纳入睡眠的客观测量指标,并评估直接针对焦虑症青少年SRPs的行为策略的影响。